- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有380家主力机构披露2025-06-30报告期持股数据，持仓量总计20.66亿股，占流通A股74.08%
- 波段诊断：
-
技术面诊股
诊断结果：5.8技术面打败了41%的股票
技术面评分前10的股票
近期的平均成本为18.42元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为18.42元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.42","date":1757236132,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2025.09.08","stock":"0.65","trade":"1.61","ind":"0.38"},{"date":"2025.09.05","stock":"0.38","trade":"0.40","ind":"1.24"},{"date":"2025.09.04","stock":"-1.19","trade":"0.36","ind":"-1.25"},{"date":"2025.09.03","stock":"-0.65","trade":"-1.72","ind":"-1.16"},{"date":"2025.09.02","stock":"0.59","trade":"-0.60","ind":"-0.45"},{"date":"2025.09.01","stock":"-0.96","trade":"0.79","ind":"0.46"},{"date":"2025.08.29","stock":"-1.48","trade":"0.14","ind":"0.37"},{"date":"2025.08.28","stock":"-0.21","trade":"-0.45","ind":"1.14"},{"date":"2025.08.27","stock":"-1.91","trade":"-3.22","ind":"-1.76"},{"date":"2025.08.26","stock":"-0.62","trade":"0.42","ind":"-0.39"},{"date":"2025.08.25","stock":"1.94","trade":"0.74","ind":"1.51"},{"date":"2025.08.22","stock":"-0.47","trade":"0.03","ind":"1.45"},{"date":"2025.08.21","stock":"0.95","trade":"-0.12","ind":"0.13"},{"date":"2025.08.20","stock":"0.58","trade":"-0.25","ind":"1.04"},{"date":"2025.08.19","stock":"-0.21","trade":"1.23","ind":"-0.02"},{"date":"2025.08.18","stock":"0.74","trade":"0.58","ind":"0.85"},{"date":"2025.08.15","stock":"-0.48","trade":"0.62","ind":"0.83"},{"date":"2025.08.14","stock":"-0.47","trade":"-2.00","ind":"-0.46"},{"date":"2025.08.13","stock":"-0.16","trade":"-0.17","ind":"0.48"},{"date":"2025.08.12","stock":"-0.21","trade":"-0.48","ind":"0.50"},{"date":"2025.08.11","stock":"-0.10","trade":"0.87","ind":"0.34"}]
上海医药,上证指数,医药商业指数
压力支撑
该股压力位为18.40元，支撑位为18.30元。
[{"text":"\u538b\u529b\u4f4d","value":"18.40","date":1757260800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.30","date":1757260800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.7资金面打败了51%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月08日 20:39
| 机构今日流向(万元) | 1122.74 | 机构5日流向(万元) | -4058.52 |
| 机构10日流向(万元) | -18071.76 | 机构20日流向(万元) | -30114.24 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加111220.19万股，其中基金净减仓84家，主力净减仓29家，暂未发现中长期投资价值。
截止2025-06-30，共380家主力机构（基金373家，一般法人6家，保险公司1家），持仓量总计206622.91万股，占流通A股74.08%
其中，基金持仓与2024-12-31相比：
增仓：56家 ，增持 536.40万股
减仓：140家 ，减持 3521.17万股
新出现在主力名单中：161家 ，持有119776.97万股
从主力名单中消失：190家 ，原持有5572.01万股
其中，基金持仓与2024-12-31相比：
增仓：56家 ，增持 536.40万股
减仓：140家 ，减持 3521.17万股
新出现在主力名单中：161家 ，持有119776.97万股
从主力名单中消失：190家 ，原持有5572.01万股
消息面诊股
诊断结果：5.7消息面打败了58%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 上药药材亮相第八届上海市对口地区特色商品展销会
2025-09-08 - 32家医药商业公司披露半年报，这10家净利润增超1
2025-09-08 - 上海医药：9月5日获融资买入3139.36万元，占
2025-09-06 - 国控、上药、华润、九州通：器械业绩对决
2025-09-05 - 第十一批集采7个品种霸屏！呼吸系统“药王”大跌，2
2025-09-05 - 上海医药获10家机构调研：目前我们拥有56项在研管
2025-09-05 - 上海医药：9月4日获融资买入4235.53万元
2025-09-05 - 医药流通行业冰火两重天：18家企业净利润下滑，仅3
2025-09-04 - 基金调研丨华泰柏瑞基金调研上海医药
2025-09-04 - 这家半年研发投入超11亿的药企，年内斩获多款过评药
2025-09-04
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-26 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-10 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-05-31 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-15 |
| 一般消息 | 高管变动 | 不再担任 | 2025-04-08 |
| 一般消息 | 高管变动 | 劳动合同到期后不再续签 | 2025-04-01 |
| 利好 | 分红转增 | 10派2.9元(含税) | 2025-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-28 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-03-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-02 |
| 一般消息 | 高管变动 | 个人原因 | 2024-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 1条 | 3条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.0行业面打败了86%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.08","price":"0.38","value":"1.61"},{"date":"2025.09.05","price":"1.24","value":"0.40"},{"date":"2025.09.04","price":"-1.25","value":"0.36"},{"date":"2025.09.03","price":"-1.16","value":"-1.72"},{"date":"2025.09.02","price":"-0.45","value":"-0.60"},{"date":"2025.09.01","price":"0.46","value":"0.79"},{"date":"2025.08.29","price":"0.37","value":"0.14"},{"date":"2025.08.28","price":"1.14","value":"-0.45"},{"date":"2025.08.27","price":"-1.76","value":"-3.22"},{"date":"2025.08.26","price":"-0.39","value":"0.42"},{"date":"2025.08.25","price":"1.51","value":"0.74"},{"date":"2025.08.22","price":"1.45","value":"0.03"},{"date":"2025.08.21","price":"0.13","value":"-0.12"},{"date":"2025.08.20","price":"1.04","value":"-0.25"},{"date":"2025.08.19","price":"-0.02","value":"1.23"},{"date":"2025.08.18","price":"0.85","value":"0.58"},{"date":"2025.08.15","price":"0.83","value":"0.62"},{"date":"2025.08.14","price":"-0.46","value":"-2.00"},{"date":"2025.08.13","price":"0.48","value":"-0.17"},{"date":"2025.08.12","price":"0.50","value":"-0.48"},{"date":"2025.08.11","price":"0.34","value":"0.87"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 百洋医药 | 14.98% | 12.23% | 5.6分 |
| 2 | 益丰药房 | 8.86% | 11.36% | 6.7分 |
| 3 | 第一医药 | 7.21% | -3.15% | 5.7分 |
| 4 | 英特集团 | 2.73% | -5.04% | 5.9分 |
| 5 | 人民同泰 | 2.64% | 2.88% | 6.3分 |
| 6 | 大参林 | 1.61% | 4.55% | 7.1分 |
| 8 | 国药一致 | 0.58% | 0.19% | 5.8分 |
| 10 | 柳药集团 | 0.05% | 0.16% | 6.2分 |
| 12 | 国科恒泰 | -0.35% | -1.73% | 5.3分 |
| 14 | 重药控股 | -1.13% | 0.00% | 5.3分 |
| 16 | 鹭燕医药 | -1.72% | 0.82% | 5.4分 |
| 18 | 海王生物 | -4.04% | -0.76% | 5.2分 |
| 20 | 塞力医疗 | -5.17% | -14.14% | 4.4分 |
| 22 | 瑞康医药 | -5.47% | 0.34% | 5.2分 |
| 24 | 九州通 | -6.15% | -1.75% | 5.9分 |
| 26 | 嘉事堂 | -6.95% | -1.33% | 5.3分 |
| 28 | 合富中国 | -8.82% | 0.00% | 5.3分 |
| 30 | 达嘉维康 | -11.71% | -1.31% | 5.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/74 ， 20/74。
[{"date":"2025-06-30","value":"6.08","vol":"3.26"},{"date":"2025-03-31","value":"1.84","vol":"1.75"},{"date":"2024-12-31","value":"6.49","vol":"4.53"},{"date":"2024-09-30","value":"5.82","vol":"5.85"},{"date":"2024-06-30","value":"4.25","vol":"4.30"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.08 | 1.84 | 6.49 | 5.82 | 4.25 |
| 行业(%) | 3.26 | 1.75 | 4.53 | 5.85 | 4.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"10.55","vol":"17.29"},{"date":"2025-03-31","value":"10.25","vol":"17.11"},{"date":"2024-12-31","value":"11.13","vol":"17.34"},{"date":"2024-09-30","value":"11.06","vol":"17.89"},{"date":"2024-06-30","value":"11.60","vol":"17.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
10.55 | 10.25 | 11.13 | 11.06 | 11.60 |
| 行业(%) | 17.29 | 17.11 | 17.34 | 17.89 | 17.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/74 ， 1/74。
[{"date":"2025-06-30","value":"1.56","vol":"-3.59"},{"date":"2025-03-31","value":"0.87","vol":"-4.22"},{"date":"2024-12-31","value":"5.75","vol":"1.15"},{"date":"2024-09-30","value":"6.14","vol":"2.06"},{"date":"2024-06-30","value":"5.14","vol":"2.35"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.56 | 0.87 | 5.75 | 6.14 | 5.14 |
| 行业(%) | -3.59 | -4.22 | 1.15 | 2.06 | 2.35 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"51.56","vol":"-58.56"},{"date":"2025-03-31","value":"-13.56","vol":"-44.86"},{"date":"2024-12-31","value":"20.82","vol":"-25.85"},{"date":"2024-09-30","value":"6.78","vol":"-50.40"},{"date":"2024-06-30","value":"12.72","vol":"-16.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
51.56 | -13.56 | 20.82 | 6.78 | 12.72 |
| 行业(%) | -58.56 | -44.86 | -25.85 | -50.40 | -16.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 11/74 ， 15/74。
[{"date":"2025-06-30","value":"0.62","vol":"0.57"},{"date":"2025-03-31","value":"0.32","vol":"0.29"},{"date":"2024-12-31","value":"1.27","vol":"1.20"},{"date":"2024-09-30","value":"0.96","vol":"0.89"},{"date":"2024-06-30","value":"0.64","vol":"0.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.62 | 0.32 | 1.27 | 0.96 | 0.64 |
| 行业(次) | 0.57 | 0.29 | 1.20 | 0.89 | 0.58 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.17","vol":"2.88"},{"date":"2025-03-31","value":"1.65","vol":"1.42"},{"date":"2024-12-31","value":"6.47","vol":"6.07"},{"date":"2024-09-30","value":"5.03","vol":"4.52"},{"date":"2024-06-30","value":"3.43","vol":"2.99"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.17 | 1.65 | 6.47 | 5.03 | 3.43 |
| 行业(次) | 2.88 | 1.42 | 6.07 | 4.52 | 2.99 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 19/74 ， 23/74。
[{"date":"2025-06-30","value":"4.51","vol":"6.90"},{"date":"2025-03-31","value":"-3.12","vol":"0.70"},{"date":"2024-12-31","value":"4.64","vol":"13.18"},{"date":"2024-09-30","value":"3.23","vol":"4.01"},{"date":"2024-06-30","value":"8.65","vol":"6.62"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 4.51 | -3.12 | 4.64 | 3.23 | 8.65 |
| 行业 | 6.90 | 0.70 | 13.18 | 4.01 | 6.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.77","vol":"0.54"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.92","vol":"0.86"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.12","vol":"0.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.77 | - | 0.92 | - | 1.12 |
| 行业 | 0.54 | 0.00 | 0.86 | 0.00 | 0.77 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 17/74 ， 1/74。
[{"date":"2025-06-30","value":"1.32","vol":"1.41"},{"date":"2025-03-31","value":"1.36","vol":"1.44"},{"date":"2024-12-31","value":"1.36","vol":"1.44"},{"date":"2024-09-30","value":"1.34","vol":"1.47"},{"date":"2024-06-30","value":"1.33","vol":"1.44"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.32 | 1.36 | 1.36 | 1.34 | 1.33 |
| 行业 | 1.41 | 1.44 | 1.44 | 1.47 | 1.44 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.00","vol":"0.99"},{"date":"2025-03-31","value":"1.04","vol":"1.01"},{"date":"2024-12-31","value":"1.03","vol":"1.02"},{"date":"2024-09-30","value":"1.02","vol":"1.04"},{"date":"2024-06-30","value":"1.02","vol":"1.03"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.00 | 1.04 | 1.03 | 1.02 | 1.02 |
| 行业 | 0.99 | 1.01 | 1.02 | 1.04 | 1.03 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 16/74 ， 15/74。
[{"date":"2025-06-30","value":"62.68","vol":"62.27"},{"date":"2025-03-31","value":"62.23","vol":"61.71"},{"date":"2024-12-31","value":"62.14","vol":"62.27"},{"date":"2024-09-30","value":"62.83","vol":"61.64"},{"date":"2024-06-30","value":"62.85","vol":"59.27"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
62.68 | 62.23 | 62.14 | 62.83 | 62.85 |
| 行业(%) | 62.27 | 61.71 | 62.27 | 61.64 | 59.27 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.99","vol":"2.48"},{"date":"2025-03-31","value":"1.93","vol":"2.47"},{"date":"2024-12-31","value":"1.92","vol":"2.50"},{"date":"2024-09-30","value":"1.98","vol":"2.19"},{"date":"2024-06-30","value":"1.99","vol":"2.08"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.99 | 1.93 | 1.92 | 1.98 | 1.99 |
| 行业(%) | 2.48 | 2.47 | 2.50 | 2.19 | 2.08 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中国银河 | 2025-08-31 | 买入 | |
| 华福证券 | 2025-08-29 | 买入 | |
| 兴业证券 | 2025-08-05 | 增持 | |
| 中邮证券 | 2025-07-02 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"50.93","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"56.17","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"37.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"45.53","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"52.69","blueLineValue":"1.42","type":"YC"}]